---
figid: PMC7494964__fonc-10-01633-g002
figtitle: Direct and indirect antitumor mechanisms of the somatostatin analogs in
  meningioma
organisms:
- NA
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC7494964
filename: fonc-10-01633-g002.jpg
figlink: pmc/articles/PMC7494964/figure/F2/
number: F2
caption: 'The direct and indirect antitumor mechanisms of the somatostatin analogs
  in meningioma. Somatostatin analogs exert their direct antitumor effects by binding
  to SSTR2, which leads to the activation of SHP1 and SHP2. SHP2 can further activate
  SHP1. SHP1 mediates antiproliferative action through inhibiting the PI3K/Akt pathway
  and induces cell cycle arrest through down-regulating cyclin D1 while up-regulating
  p27/Kip 1. Suppressing secretion of VEGF and GH/IGF-1 and activating the immune
  system are involved in indirect antitumor mechanisms of somatostatin analogs. Abbreviations:
  Akt, protein kinase B; GH, growth hormone; insulin-like growth factor-1 (IGF-1);
  PI3K, phosphatidylinositol 3-kinase; SHP1, SH2-containing phosphatase-1; SHP2, SH2-containing
  phosphatase-2; SSTR, somatostatin receptor; and VEGF, vascular endothelial growth
  factor.'
papertitle: Clinical Significance of Somatostatin Receptor (SSTR) 2 in Meningioma.
reftext: Wei Wu, et al. Front Oncol. 2020;10:1633.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9731519
figid_alias: PMC7494964__F2
figtype: Figure
redirect_from: /figures/PMC7494964__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7494964__fonc-10-01633-g002.html
  '@type': Dataset
  description: 'The direct and indirect antitumor mechanisms of the somatostatin analogs
    in meningioma. Somatostatin analogs exert their direct antitumor effects by binding
    to SSTR2, which leads to the activation of SHP1 and SHP2. SHP2 can further activate
    SHP1. SHP1 mediates antiproliferative action through inhibiting the PI3K/Akt pathway
    and induces cell cycle arrest through down-regulating cyclin D1 while up-regulating
    p27/Kip 1. Suppressing secretion of VEGF and GH/IGF-1 and activating the immune
    system are involved in indirect antitumor mechanisms of somatostatin analogs.
    Abbreviations: Akt, protein kinase B; GH, growth hormone; insulin-like growth
    factor-1 (IGF-1); PI3K, phosphatidylinositol 3-kinase; SHP1, SH2-containing phosphatase-1;
    SHP2, SH2-containing phosphatase-2; SSTR, somatostatin receptor; and VEGF, vascular
    endothelial growth factor.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SSTR2
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - PTPN11
  - PTPN6
  - NR0B2
  - AKT1
  - AKT2
  - AKT3
  - IFI27
  - PSMD9
  - ZNRD2
  - DCTN6
  - TMED7
  - H3P23
  - CDKN1B
  - CIB1
  - IGF1
  - Pvf1
  - Pvf2
  - Pvf3
  - Pvr
  - csw
  - Akt
  - tum
  - hop
  - DCTN6-p27
  - dap
  - CG9588
  - CycE
  - cyc
  - Somatostatin
  - system Meningioma
  - Meningioma
---
